Drug Manufacturing Innovation Act of 2022
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 2022
Referred to the Subcommittee on Health.
Mar 8, 2022
Introduced in House
Mar 8, 2022
Referred to the House Committee on Energy and Commerce.
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Drug Manufacturing Innovation Act of 2022
This bill requires the Food and Drug Administration to establish a program to support innovative approaches to pharmaceutical product design and manufacturing, including through grants, regulatory guidance, and working groups.
What's happening now
Referred to the Subcommittee on Health.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cosponsors
1
Cite this page
U.S. Congress. (2026). H.R. 6988: Drug Manufacturing Innovation Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6988/
"H.R. 6988: Drug Manufacturing Innovation Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6988/.
H.R. 6988, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6988/.
[H.R. 6988: Drug Manufacturing Innovation Act of 2022](https://openamerica.io/bill/117-HR-6988/)